Survival Outcomes of Local Compared With Systemic First Treatment of Non-Small Cell Lung Cancer Brain Metastases
ObjectiveThis retrospective study evaluated the survival advantage of local treatment targeted to brain metastases, relative to systemic therapy, as the first option for brain metastases of non-small cell lung cancer (NSCLC).MethodsFirst reviewed were 291 cases of NSCLC brain metastases from two cen...
Enregistré dans:
Auteurs principaux: | Hong-Mei Liu, Chun-Liu Meng, Lu-Jun Zhao |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/1227e6a823a2417c9ed0c53333d4ab7b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Response and safety of whole‐brain radiotherapy plus temozolomide for patients with brain metastases of non‐small‐cell lung cancer: A meta‐analysis
par: Jianguo Han, et autres
Publié: (2021) -
The Burden of Peritoneal Metastases from Gastric Cancer: A Systematic Review on the Incidence, Risk Factors and Survival
par: Anouk Rijken, et autres
Publié: (2021) -
Efficacy of PD‐1/PD‐L1 inhibitors in patients with non‐small cell lung cancer and brain metastases: A real‐world retrospective study in China
par: Jiamin Sheng, et autres
Publié: (2021) -
Oligometastatic non-small-cell lung cancer: current treatment strategies
par: Richard PJ, et autres
Publié: (2016) -
Current progress and outcomes of clinical trials on using epidermal growth factor receptor-tyrosine kinase inhibitor therapy in non-small cell lung cancer patients with brain metastases
par: Ling-Ling Kong, et autres
Publié: (2017)